T. Rowe Price reports 5% Mediwound stake

T. Rowe Price Associates, Inc. reported beneficial ownership of 641,075 shares of Mediwound Ltd. common stock, representing 5.0% of the class as of June 30, 2026.

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. reported beneficial ownership of 641,075 shares of Mediwound Ltd. common stock, representing 5.0% of the class as of June 30, 2026. The firm has sole voting power over 638,398 shares and sole dispositive power over 641,075 shares, with no shared voting or dispositive power.

The shares relate to Mediwound’s common stock with CUSIP M68830112. T. Rowe Price Associates states that this report should not be construed as an admission that it is the beneficial owner of these securities, and it expressly denies such beneficial ownership.

Key Figures

Shares beneficially owned: 641,075 shares Percent of class: 5.0% Sole voting power: 638,398 shares +4 more

7 metrics

Shares beneficially owned 641,075 shares Amount beneficially owned as of 06/30/2026

Percent of class 5.0% Ownership percentage of Mediwound common stock

Sole voting power 638,398 shares Shares over which T. Rowe Price Associates has sole power to vote

Shared voting power 0 shares Shares over which voting power is shared

Sole dispositive power 641,075 shares Shares over which T. Rowe Price Associates has sole power to dispose

Shared dispositive power 0 shares Shares over which dispositive power is shared

CUSIP M68830112 Identifier for Mediwound Ltd common stock

Key Terms

beneficially owned, sole voting power, dispositive power, percent of class, +1 more

5 terms

beneficially owned financial

"Ownership (a) | Amount beneficially owned: 641075"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole power to vote or to direct the vote: 638398"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole power to dispose or to direct the disposition of: 641075"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class financial

"Percent of class: 5.0 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

CUSIP financial

"CUSIP No.: M68830112"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in Mediwound Ltd (MDWD) does T. Rowe Price Associates report?

T. Rowe Price Associates reports beneficial ownership of 641,075 shares of Mediwound Ltd common stock, representing 5.0% of the outstanding class as of June 30, 2026, crossing the typical 5% reporting threshold.

How much voting power does T. Rowe Price Associates have in Mediwound Ltd (MDWD)?

T. Rowe Price Associates has sole voting power over 638,398 shares of Mediwound Ltd and no shared voting power. It also holds sole dispositive power over 641,075 shares, giving it unilateral authority to vote and dispose of those shares.

What is the percentage of class owned by T. Rowe Price Associates in MDWD?

The reported stake is 5.0% of Mediwound Ltd’s common stock. This level of ownership triggers Schedule 13G reporting requirements and reflects a sizable institutional position in the company’s equity.

Does T. Rowe Price Associates admit beneficial ownership of its Mediwound (MDWD) shares?

T. Rowe Price Associates explicitly denies beneficial ownership of the Mediwound shares reported and states that its report should not be construed as an admission that it is the beneficial owner of these securities.

What type of security in Mediwound Ltd (MDWD) is held by T. Rowe Price Associates?

The position is in Mediwound Ltd common stock, identified by CUSIP M68830112. The report covers equity holdings only, not other types of securities such as preferred stock or debt instruments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 10:42 AM Accepted by SEC EDGAR 08/14/2026 - 10:38 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MEDIWOUND LTD

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

M68830112

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): M68830112

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 638,398.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 641,075.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

641,075.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MEDIWOUND LTD
(b)	Address of issuer's principal executive offices: 42 HAYARKON STREET, YAVNE, L3, 8122745
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: M68830112
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 641075
(b)	Percent of class: 5.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 638398
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 641075
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	08/14/2026